Half Year 2023 Vistin Pharma ASA Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Vistin Pharma Quarterly Report Q2 2023 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Kjell-Erik Nordby, Chief Executive Officer. Please go ahead.
()
Thank you very much, and welcome to the second quarter presentation of Vistin Pharma. As usual, we will start with the highlights of the quarter. I'm pleased to inform you that Vistin is continuing doing well in 2023. The revenue in the second quarter ended at NOK 107 million compared to NOK 69 million in the second quarter last year. The reason for this significant increase in revenue is mainly driven from the increased volume from the new production line that we invested in and opened in 2022 compared to the same quarter last year, which was in the beginning of the operation of the new line. So year-to-date, the revenue is -- was NOK 208 million
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
